Wednesday, July 23, 2014   

GSK to sell oncology arm to Novartis
(04-22 14:22)

British pharmaceutical giant GlaxoSmithKline is to sell its oncology business to peer Novartis for US$16 billion and to buy the Swiss company's vaccines division, GSK announced on Tuesday.
Under a "major three-part transaction'' GSK and Novartis have agreed also to create a consumer healthcare business, according to a statement issued by GlaxoSmithKline. --AFP
   
Other Business breaking news:
Hang Seng hits high since December (07-22 16:30)
European markets open higher (07-22 15:33)
Credit Suisse posts heavy loss after fine (07-22 15:07)
Nikkei closes higher on weaker yen (07-22 14:09)
Hang Seng jumps by break (07-22 12:30)
Nikkei up by break (07-22 10:59)
Taiwan exports surge on higher mobile demand (07-21 17:46)
HK inflation eases in June (07-21 17:36)
China, Switzerland sign currency swap deal (07-21 17:27)
Hang Seng, Shanghai end lower (07-21 16:38)

More breaking news >>

© 2014 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts

 


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2014, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.